← Open Payments lookup

SANJEEV KAMAT: Open Payments

NPI 1649375288 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,348 in 97 payments from 13 companies in 2025. Trend: 2023 $1,739 · 2024 $2,472 · 2025 $2,348

Food & beverage: $2,341Education: $8
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$547
Alkermes, Inc.14$460
Vanda Pharmaceuticals Inc.13$305
E.R. Squibb & Sons, L.L.C.23$275
ABBVIE INC.6$167
Janssen Pharmaceuticals, Inc7$150
Otsuka America Pharmaceutical, Inc.1$122
Lundbeck LLC3$69
Lilly USA, LLC3$62
Teva Pharmaceuticals USA, Inc.3$57

Products named: CAPLYTA, ARISTADA, FANAPT, COBENFY, REXULTI, VRAYLAR, LYBALVI, INVEGA SUSTENNA.

Industry payments across MO — which companies pay providers there.